Figure 8 Investment Strategies LLC Takes $626,000 Position in The Cooper Companies, Inc. $COO

Figure 8 Investment Strategies LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, Holdings Channel.com reports. The institutional investor bought 8,728 shares of the medical device company’s stock, valued at approximately $626,000.

A number of other institutional investors have also added to or reduced their stakes in COO. BlackRock Inc. bought a new position in Cooper Companies in the second quarter worth approximately $1,077,762,000. Wellington Management Group LLP raised its position in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the period. Generation Investment Management LLP acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $233,539,000. Diamond Hill Capital Management Inc. lifted its holdings in shares of Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Up 0.9%

Shares of NASDAQ:COO opened at $75.76 on Wednesday. The stock has a market cap of $14.78 billion, a price-to-earnings ratio of 64.20, a PEG ratio of 1.99 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The business’s 50 day moving average is $71.41 and its 200 day moving average is $71.18.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the firm earned $0.96 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on COO. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. Citigroup restated a “neutral” rating and set a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Needham & Company LLC reduced their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.